CanBas Co., Ltd. (TYO:4575)
Japan · Delayed Price · Currency is JPY 678.00
-14.00 (-2.02%)
May 12, 2026, 3:30 PM JST
CanBas Market Cap
CanBas has a market cap or net worth of 13.23 billion as of May 12, 2026. Its market cap has decreased by -19.53% in one year.
Market Cap
13.23B
Enterprise Value
11.03B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
678.00
Market Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 13.23B, an increase of 57.77%. That is a compound annual growth rate of 2.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 13.23B | -13.82% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 18.80B |
| Stella Pharma | 18.57B |
| Renascience | 17.33B |
| ReproCELL | 16.25B |
| Immuno-Biological Laboratories | 12.53B |
| Nano Holdings | 11.17B |
| Kidswell Bio | 11.17B |
| CellSeed | 10.31B |